Keith Poulsen’s jaw dropped when farmers showed him images on their cellphones at the World Dairy Expo in Wisconsin in October. A livestock veterinarian at the University of Wisconsin, Poulsen had seen sick cows before, with their noses dripping and udders slack. But the scale of the farmers’ efforts to treat the sick cows stunned him. They showed videos of systems they built to hydrate hundreds...
Everyday physical activity, like going for a short walk or playing with the kids, may provide short-term benefits for cognitive health, equivalent to reversing four years of cognitive aging. That was a key finding for my colleagues and me in our new study, which was published in the journal Annals of Behavioral Medicine. Prior to enrollment into a study of diet and dementia risk, we asked a...
The federal Anti-Kickback Statute (AKS) is a crucial law in the healthcare industry. It criminalizes the act of paying someone to refer patients or generate business when any form of state or federal healthcare program funds—such as Medicare, Medicaid, CHAMPUS, and TriCare—are involved. Many states have their own versions of this law. While it seems straightforward, many physicians and...
In the intricate world of behavioral healthcare, where reimbursement policies and insurance claims are critical to operational success, a new and concerning trend has emerged, potentially impacting how providers manage their financial operations. This silent contracting trend involves Florida Blue’s recent policy changes regarding laboratory service claims and their significant implications....
Unusual variations in the cellular protein factory can skew development, help cancer spread and more. But ribosome variety may also play biological roles, scientists say. In the 1940s, scientists at the recently established National Cancer Institute were trying to breed mice that could inform our understanding of cancer, either because they predictably developed certain cancers or were...
Negotiations to reduce drug prices can sometimes shift costs onto consumers. rudisill/iStock via Getty Images Plus ~~~~~ When it comes to drug pricing, the Trump and Biden-Harris administrations both have some very modest wins to tout. As director of the Health Outcomes, Policy, and Evidence Synthesis group at the University of Connecticut School of Pharmacy, I teach and study about the ethics...
